Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview.
Ontology highlight
ABSTRACT: Antibodies are considered as an excellent foundation to neutralize pathogens and as highly specific therapeutic agents. Antibodies are generated in response to a vaccine but little use as immunotherapy to combat virus infections. A new generation of broadly cross-reactive and highly potent antibodies has led to a unique chance for them to be used as a medical intervention. Neutralizing antibodies (monoclonal and polyclonal antibodies) are desirable for pharmaceutical products because of their ability to target specific epitopes with their variable domains by precise neutralization mechanisms. The isolation of neutralizing antiviral antibodies has been achieved by Phage displayed antibody libraries, transgenic mice, B cell approaches, and hybridoma technology. Antibody engineering technolog
SUBMITTER: Ali MG
PROVIDER: S-EPMC7648849 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA